Key Takeaways
- The market approach values a dental practice by referencing closed comparable sales and adjusting for differences, and it can break down without careful segmentation and documentation.
- Correct buyer-type segmentation can be essential: private dentists are valued on SDE while DSOs use adjusted EBITDA, and mixing the two produces distorted results.
- Only closed transactions qualify as comps; asking prices systematically overstate value and should never be used in the analysis.
- Normalization requires documented, defensible add-backs, especially owner-compensation replacement and discretionary expenses, because unsupported adjustments are routinely rejected in diligence and multiplied by the transaction multiple.
- McLerran & Associates delivers diligence-grade, CPA-led comparable-sales analysis that holds up under buyer scrutiny and can help sellers avoid re-trades.
Schedule A Discovery Call with McLerran & Associates
7 Steps to Analyze Comparable Sales for a Dental Practice Valuation
- Segment the market by buyer type and size before you touch a number.
- Source real comparable sales data, using closed transactions only.
- Build the comp database.
- Calculate the four multiples.
- Normalize and adjust.
- Reconcile to a range and cross-check.
- Pressure-test and document.
Step 1: Segment The Market By Buyer Type And Size Before You Touch A Number
The central rule in dental comparable-sales analysis is simple: SDE for doctor-to-doctor, adjusted EBITDA for DSO. Seller’s discretionary earnings (SDE) means pre-tax profit plus the owner’s full compensation, benefits, interest, depreciation, amortization, and documented discretionary expenses. It measures the total economic return available to a buyer who will personally replace the selling dentist.
Adjusted EBITDA means earnings before interest, taxes, depreciation, and amortization after deducting a market-rate salary for the owner’s clinical production. It measures what the practice earns as a transferable business when a hired associate replaces the owner. SDE is larger than EBITDA for the same practice, so the multiples applied to each differ materially. Comparing a quoted SDE multiple to a quoted EBITDA multiple without examining the denominator creates a misleading picture.
Comparing a solo doctor-to-doctor sale to a DSO platform acquisition creates a cardinal comparability error. The buyer, the earnings definition, the consideration structure (100% cash at close versus a mix of cash, rollover equity, and earnout), and the seller’s post-close role all differ. DSO offers can appear a full turn richer than private bids, yet the headline multiple often arrives partly as equity or contingent payments. Mixing the two buyer populations in a single comp set produces a distorted range that does not reflect either market accurately.
Apply these segmentation filters before pulling a single transaction:
- Buyer type: private dentist (SDE-based) versus DSO or private equity (EBITDA-based).
- Size band: earnings and collections, because a small tuck-in and a regional platform trade at structurally different multiples.
- Specialty: keep general dentistry comps for a general practice; specialty-specific multiples require specialty-specific comps, and published data for any single specialty is thin.
- Geography: market dynamics, payer mix, and buyer appetite vary by region.
- Transaction scope: asset sale versus equity sale, and whether real estate is included or excluded.
Get A Diligence-Grade Valuation
Step 2: Source Real Comparable Sales Data
Once the market is segmented, the next question is where the transactions come from. The first rule of sourcing is that asking prices are not comps. At the average level, dental practice sellers asked 3.22× SDE versus 2.63× achieved, an 18.3% reduction, and asked 1.13× collections versus 0.77× achieved, a 31.9% reduction. Building a comp set from listing prices systematically overstates what the market actually clears.
Closed dental transaction data comes from several source categories, each with documented limitations:
- Proprietary broker transaction databases: Often the most relevant source for dental-specific closed deals. A dental-only advisor’s own transaction history, with known buyer types, normalized earnings, and deal structures, provides richer analytical capability than a broad commercial database across all industries.
- Paid commercial private-transaction databases: Platforms that aggregate private-market deal data. Even the most comprehensive of these capture an estimated 15%–25% of all private transactions, with coverage heavily skewed toward deals above $25 million in enterprise value. Small dental practice transfers, which make up most of the market, remain largely undocumented. A five-year dental asset-transaction sample from one widely used database totaled 35 observations, with roughly half concentrated in two states, which is far too narrow to serve as a national benchmark for a specific practice.
- Industry goodwill and transaction studies: The Goodwill Registry, published annually since 1981, contains more than 2,567 goodwill transaction reports spanning medical and dental practices and organizes data by specialty, state, and location. It reports goodwill as a percentage of gross collections rather than whole-practice enterprise value, so it supplements EBITDA-based comp analysis.
- Industry association market reporting: The IBBA and M&A Source Market Pulse surveys report closed-deal multiples by size band across all industries. Their Q2 2026 survey of 255 advisors covering 181 closed deals reported average multiples by deal size, and dental-specific observations within any single size band form only a small subset of the total.
The structural reality is that there is no MLS and no readily pullable comparable-sales database for dental practices. A comp set for a specific practice is inherently narrow and must be filtered, disclosed, and weighted rather than applied as a rule. This reality is a key reason a dental-only advisor’s own closed-transaction history, with documented buyer types, earnings definitions, and deal structures, often becomes the most relevant and least accessible source in the market.
Step 3: Build The Comp Database
A comp is only useful when you can match it to the subject practice field by field. The list below shows the fields every comp should capture and why each one changes whether the comparison holds.
- Closing date: Market conditions shift, so comps older than 3 to 5 years carry less weight.
- Geography: Buyer appetite, payer mix, and achievable multiples vary by market.
- Buyer type: Determines the correct earnings metric, SDE versus adjusted EBITDA.
- Collections or revenue: Serves as the size-band anchor. Use collections, because collections represent cash received.
- Adjusted EBITDA or SDE: Provides the denominator for the multiple and must match the buyer type.
- Purchase price: Provides the numerator and should clarify whether it is cash at close, headline enterprise value, or includes earnout and rollover equity.
- Real estate included: Real estate is appraised and transacted separately, and including it inflates the practice multiple.
- Operatories: Acts as a capacity proxy that affects expansion potential and buyer appetite.
- Active patients: Represents the core transferable asset, but the definition matters because 12-month, 18-month, and 24-month windows produce materially different counts.
- Provider count: Indicates owner-dependent versus associate-supported production, which affects transferability and the multiple.
- Hygiene percentage of revenue: Hygiene above roughly 30% of collections is associated with a valuation premium because it signals recurring, provider-independent revenue.
- Payer mix: Fee-for-service, PPO, and Medicaid or HMO concentration affect margin and buyer risk assessment.
- Growth trend: Stable or growing collections support the multiple, while declining trends compress it.
Definitional traps can undermine this work. “Active patient” definitions vary by software and by practice, collections and production record different accounting facts, and a reported purchase price may reflect cash at closing, maximum earnout potential, or expected total consideration. Without clarity on consideration structure, calculated multiples can vary by 30%–50% or more.
Step 4: Calculate The Four Multiples
Four multiples are standard in dental comparable-sales analysis, and each one should be calculated for every transaction in the comp set:
- Price ÷ Collections
- Price ÷ Adjusted EBITDA
- Price ÷ SDE
- Price ÷ Active Patients
The following is a clearly labeled illustrative example only and does not serve as a benchmark or a promise of any specific outcome for any practice.
Assume a subject practice with $1,200,000 in collections, $300,000 SDE, and $180,000 adjusted EBITDA. Three illustrative closed comps, all private-buyer transactions, asset sales, and real estate excluded, produce the following:
- Comp A: $840,000 price on $1,100,000 collections and $280,000 SDE, which equals 0.76× collections and 3.00× SDE.
- Comp B: $900,000 price on $1,250,000 collections and $320,000 SDE, which equals 0.72× collections and 2.81× SDE.
- Comp C: $780,000 price on $1,050,000 collections and $260,000 SDE, which equals 0.74× collections and 3.00× SDE.
- Median: 0.74× collections and 3.00× SDE.
Applying the median price-to-SDE multiple of 3.00× to the subject practice’s $300,000 SDE produces an illustrative indicated value of $900,000. Applying the median price-to-collections multiple of 0.74× to $1,200,000 produces $888,000. Use that figure to cross-check the SDE result rather than to set value on its own.
Median is usually the preferred starting point over mean in small samples because a single outlier transaction can materially distort a mean. With 3 to 5 comps, median and mean may differ meaningfully, so the analysis should disclose which measure it uses and why.
Step 5: Normalize And Adjust
Normalization restates historical results as they would appear under ordinary post-closing ownership. The most significant adjustments in a dental practice usually fall into these categories:
- Owner-compensation replacement: Remove the owner’s W-2 compensation and charge a market clinical rate for the owner’s production, typically expressed as a percentage of the owner’s adjusted production. Per ADA guidance for dental associates, replacement dentist pay is benchmarked at roughly 30% of adjusted production, with a national range of about 25% to 35%. The net adjustment can be positive, near zero, or negative depending on how the owner was paid relative to market.
- Discretionary and non-recurring add-backs: Personal vehicles, above-market family payroll, one-time legal fees, and personal insurance are common examples. A defensible add-back is an expense a new owner genuinely will not incur and that the seller can evidence with documentation. A “one-time” expense that has recurred for 3 consecutive years is treated as a run rate and rejected.
- Rent-to-market: When a practice pays above-market rent to an owner-controlled building entity, the excess over fair market rent is a legitimate add-back. Below-market rent inflates adjusted EBITDA and will be adjusted back down by a buyer. An independent fair-market-rent opinion, rather than a broker’s estimate, is required in either case.
- Qualitative adjustment factors: Provider dependency, payer mix, hygiene strength, and growth trend move the multiple within the range rather than creating standalone dollar adjustments. Dental practices where the owner performs 90% or more of production may face valuation reductions because a buyer cannot underwrite production revenue that walks out the door with the seller. Heavy Medicaid or HMO payer concentration can compress multiples, while hygiene revenue above roughly 30% of collections is associated with premium pricing.
That same test, whether a new owner would incur the expense and whether the seller can prove it, governs every add-back. Qualitative factors work differently. They do not create dollar adjustments but instead move the practice toward the top or bottom of the comp range. Every add-back claimed in normalization will be scrutinized by buyers, and documentation carries significant weight.
Step 6: Reconcile To A Range And Cross-Check
Reconciliation starts by weighting comps by comparability. A transaction from the same geography, same buyer type, same size band, and same transaction scope in the last 2 years earns more weight than a 5-year-old deal from a different state. The output should be a range rather than a single point estimate. The market-approach range should then be cross-checked against the income approach, which applies a multiple to normalized earnings, and the asset approach, which treats equipment, leasehold improvements, and supplies as a floor. For a deeper look at how those approaches interact, see Dental Practice Valuation: Why The Numbers Differ and Dental Practice Sale Multiples: 2026 Valuation Guide.
McLerran & Associates brings a specific set of capabilities to this reconciliation step. The firm is a dental-only sell-side advisor and advocate, never representing the buyer, with roughly 35 years in business, more than 10,000 dental practices evaluated at a pace of roughly 500 per year, approximately 2,000 successful practice sales, and roughly $2 billion in closed transaction volume. Every engagement is built on a CPA-led EBITDA analysis and practice valuation. The firm works private-buyer and DSO transactions in roughly equal measure, which provides a genuine side-by-side view of both markets. Its transaction rate is roughly 85%–90%, versus an industry norm closer to 35%–40%, and clients achieve on average roughly 30% higher valuations than owners who sell on their own.
How A Weak Comp Analysis Gets Re-Traded In Diligence
A comparable-sales analysis built on asking prices or mismatched buyer populations produces a number that often fails in quality-of-earnings review. Buyers routinely strip aggressive add-backs, retrade on undisclosed liabilities, and adjust price for retention risk. Every dollar of add-backs rejected in diligence reduces normalized earnings, and that reduction is multiplied by the transaction multiple, so a $300,000 overstatement of adjusted EBITDA at a 6× multiple destroys $1.8 million of enterprise value. The letter of intent is typically non-binding and carries exclusivity, which means the seller is negotiating alone against a clock at exactly the moment the add-back schedule is tested.
The practical fix relies on diligence-grade work done up front. A CPA-led EBITDA analysis with every add-back documented and defensible before the practice goes to market, combined with a competitive process that keeps other vetted bidders in the room, can materially reduce re-trade risk. When a buyer knows that other qualified buyers are waiting, the incentive to re-trade on marginal findings is substantially reduced.
Request A Comprehensive Valuation
Step 7: Pressure-Test And Document
Pressure-testing the analysis before it reaches any buyer protects value. Before the analysis goes to market, document every assumption, including the source of each comp, the closing date, the fields captured, the adjustments made, and the rationale for each. That documentation is what keeps the comp file audit-ready. A CPA, ideally with dental-industry experience, should review the analysis before it goes to market.
A reliable normalization process separates personal, discretionary, unusual, and nonrecurring expenses from the costs required to operate the practice. It then reconciles production, collections, adjustments, payroll, owner compensation, and major capital expenditures. Only after that reconciliation should the supporting documents, such as tax returns, monthly financial statements, production reports, payer information, employee records, leases, contracts, and equipment lists, be assembled in a controlled data room. The AICPA & CIMA valuation services framework requires a valuation to define its purpose, scope, ownership interest, valuation date, methods, assumptions, and important limitations, so a dental valuation answers the specific question it was engaged for rather than serving as a universal price tag.
EBITDA Vs. SDE Vs. Percentage Of Collections: What Each Multiple Actually Measures
The seven steps above assume you already have a working sense of what each multiple measures. This section steps back to define the three metrics side by side, so the numbers in your comp file can be read correctly.
SDE measures the total economic return available to a single owner-dentist who will personally replace the seller. It adds back the owner’s full compensation and benefits, interest, depreciation, amortization, and documented discretionary expenses to pre-tax profit. Private dentist buyers price on SDE because they are buying a job plus a return on investment.
Adjusted EBITDA measures what the practice earns as a transferable business after deducting the market cost of hiring an associate to replace the owner’s clinical production. DSOs and institutional buyers price on adjusted EBITDA because they are buying a business that must generate returns without relying on the selling dentist. The U.S. Bureau of Labor Statistics reported the median annual wage for dentists was $176,110 as of May 2025, a commonly referenced benchmark for owner-compensation normalization, though the actual replacement cost depends on the owner’s production level, specialty, and geography.
Percentage of collections functions as a shorthand. Two dental practices each collecting $1 million can differ by roughly $300,000 in value at the same SDE multiple. A 55%-overhead practice with $450,000 SDE values near $790,000, while a 72%-overhead practice with $280,000 SDE values near $490,000. A revenue multiple is really an earnings multiple times an assumed profit margin, and that margin assumption is exactly what gets tested in diligence.
Rules of thumb like the “50-40-30 rule” or “3 times profit” can mislead in dentistry for the same reason. Two practices with identical collections can carry very different overhead and therefore very different earnings. A quoted multiple carries meaning only when you know what it is a multiple of and how it was calculated. For a deeper treatment of how formulas and multiples interact, see Dental Practice Valuation Formula For Selling Your Practice.
Common Comparable-Sales Mistakes
Each of the seven steps has a failure mode. These are the errors that most often undermine an otherwise sound comp analysis.
- Asking prices treated as comps. Listing prices systematically overstate achieved values, and only closed transactions qualify as comps.
- Mismatched buyer populations. Mixing private-dentist and DSO transactions in a single comp set conflates two different markets with different earnings definitions and consideration structures.
- Revenue multiples without profitability. A percentage-of-collections figure conceals overhead and earnings, so the multiple must be applied to the correct earnings metric.
- Undisclosed or unsupported add-backs. Add-backs that cannot be evidenced will be disallowed in diligence. As noted earlier, a disallowed add-back costs more than its face value because the transaction multiple magnifies it.
- Ignoring real estate. Including dentist-owned real estate in the practice price inflates the multiple. The ADA treats the operating practice and dentist-owned real estate as separate assets, and lenders may treat them differently as well.
- False precision. A comp set of 3 to 5 transactions supports a range with disclosed assumptions rather than a single point estimate.
Conclusion
McLerran & Associates is a dental-specific sell-side advisor for analyzing comparable sales for a dental practice valuation because it builds a CPA-led, diligence-grade EBITDA analysis and valuation up front, has evaluated more than 10,000 dental practices, and runs a competitive process that helps the resulting value hold up under buyer scrutiny instead of getting re-traded. The market approach is only as strong as the comps behind it and the discipline applied to them, and discipline means closed transactions only, correctly segmented by buyer type, with documented fields, defensible add-backs, and a reconciled range that can survive quality-of-earnings review. McLerran & Associates performs this analysis rather than publishing benchmarks, dental-only, sell-side only, CPA-led and diligence-grade, so the value holds when it matters most.
Frequently Asked Questions
Where Does Closed Dental Transaction Data Come From?
Closed dental transaction data comes from several sources, and none of them is comprehensive on its own. Proprietary broker databases, built from an advisor’s own closed deals, are often the most relevant because they include known buyer types, normalized earnings definitions, and deal structures. Commercial private-transaction databases aggregate data across industries but capture only a fraction of small dental deals, and their dental-specific samples can be very thin and geographically concentrated. Industry goodwill and transaction studies, such as the Goodwill Registry, report intangible goodwill values as a percentage of collections across hundreds of health care transactions, organized by specialty and geography. Industry association surveys report closed-deal multiples by size band but do not isolate dental-specific observations. Because no single source is complete, a defensible comp set draws from multiple sources, discloses its sample size and limitations, and weights observations by comparability rather than treating every transaction equally.
Why Are Asking Prices Not Comps?
Asking prices reflect a seller’s aspirations rather than what the market will actually pay. Closed-transaction data consistently shows that dental practices sell at a meaningful discount to their listed prices. At the average level, sellers have asked materially more on both a collections multiple and an SDE multiple basis than what closed deals have actually achieved. A comp set built from asking prices will systematically overstate the achievable value of a subject practice, producing a number that gets corrected downward the moment a buyer’s quality-of-earnings team reviews the financials. Only closed transactions, with documented consideration structures and verified earnings, qualify as true comps.
What’s the Difference Between SDE and EBITDA in a Dental Practice Sale?
As covered in Step 1, SDE measures the return available to an owner-dentist who replaces the seller, and adjusted EBITDA measures what the practice earns once a hired associate replaces that production. The practical difference lies in which buyer type prices on which metric. Private dentist buyers typically price on SDE because they are buying a job plus a return, and DSOs and institutional buyers typically price on adjusted EBITDA because they are buying a transferable business. A quoted multiple carries meaning only when you know which earnings measure sits in the denominator.
How Many Comps Are Enough?
There is no fixed minimum, and the quality of each comp usually matters more than the count. A few transactions with a clear reason for comparison, such as same buyer type, same size band, same geography, same transaction scope, and closed within the last 3 to 5 years, can carry more analytical weight than a long list with no clear fit. In practice, dental-specific comp sets for a particular practice type and geography can be very small, sometimes 3 to 5 transactions or fewer. When the sample is this narrow, the analysis should disclose that limitation explicitly, weight comps by comparability, and cross-check the market-approach range against the income and asset approaches rather than relying on the comp set alone. A small, well-filtered, well-documented comp set is often more defensible than a large set of poorly matched transactions.
Is Real Estate Included in the Comp?
Real estate should be treated as a separate asset from the operating dental practice, and every comp in the database should be flagged for whether real estate was included or excluded from the reported purchase price. Including dentist-owned real estate in the practice price inflates the apparent multiple, and excluding it produces a cleaner comparison of the practice’s operating value. When building a comp set, match the subject practice’s real estate treatment to the comps. If the subject practice’s real estate is being sold separately, use comps where real estate was also excluded. If the subject practice’s real estate is included in the transaction, use comps where it was included. Mixing the two creates an apples-to-oranges comparison that distorts the indicated range.
How Are Adjustments Made to Comparable Sales?
Adjustments in a comparable-sales analysis operate at two levels. Quantitative adjustments, such as owner-compensation replacement, documented add-backs, and rent-to-market corrections, are applied to the subject practice’s earnings to arrive at a normalized earnings figure that is comparable to what the comps report. Qualitative adjustments, such as provider dependency, payer mix, hygiene strength, growth trend, and lease terms, are used to select a position within the range indicated by the comp set rather than to create standalone dollar adjustments. Every adjustment must be defensible, supported by documentation, consistent across all 3 years of financials presented, and able to withstand a buyer’s quality-of-earnings review. As noted earlier, a disallowed add-back costs more than its face value because the transaction multiple magnifies it.
How Are Comps Used in Buyer Diligence?
Buyers use comparable-sales data to test whether the seller’s asking price aligns with what the market has actually paid for similar practices. A buyer’s quality-of-earnings team will review the seller’s normalized earnings, challenge unsupported add-backs, and compare the implied multiple to their own view of the market. If the seller’s comp analysis was built on asking prices, mismatched buyer populations, or undocumented add-backs, the buyer’s team will identify the gaps and use them to justify a price reduction, or retrade, after the letter of intent is signed. A seller whose comp analysis was built to diligence-grade standards, with documented sources, defensible add-backs, and a reconciled range, is in a much stronger position to hold the agreed value through closing.
When Should a Professional Run the Analysis?
A professional comparable-sales analysis should be completed before the practice goes to market. Ideally this occurs 12 to 24 months before a planned transition as part of the preparation and valuation phase, though overall transition planning often begins earlier, typically 3 to 5 years before the expected transition date. Running the analysis early gives the owner time to act on findings, address provider dependency, build hygiene production, document add-backs, negotiate a lease extension, or make operational improvements that move the practice toward the top of its comparable range. A valuation done after an unsolicited offer arrives, or after a letter of intent is signed, leaves the seller defending numbers they did not prepare and negotiating from a position of weakness. The analysis is best performed by a dental-specific advisor with access to closed dental transaction data, CPA-led normalization capability, and experience defending the resulting number in buyer diligence.